Occult residual ovarian tissue at the time of minimally invasive risk reducing surgery in women with BRCA mutations.

Autor: Polan RM; Department of Gynecologic Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA. Electronic address: rosa.m.polan@gmail.com., Ali-Fehmi R; Department of Pathology, University of Michigan, Ann Arbor, MI, USA., Grace AK; Department of Gynecologic Oncology, Northwestern Prentice Women's Hospital, Chicago, IL, USA., Mattei LH; Department of Gynecologic Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA., Tanner EJ 3rd; Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, MD, USA., Morris RT; Department of Gynecologic Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2024 Oct; Vol. 189, pp. 37-40. Date of Electronic Publication: 2024 Jul 15.

Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.

Autor: Russo S; National Cancer Institute, Division of Cancer Prevention, 9609 Medical Center Drive, Rockville, MD 20892-9785, USA. Electronic address: sandra.russo@nih.gov., Walker JL; Stephen Cancer Center, OUHSC, Oklahoma City, OK 73104, USA. Electronic address: joan-walker@ouhsc.edu., Carlson JW; Cancer Research for Ozarks, 1235 E. Cherokee, Springfield, MO 65804, USA. Electronic address: jay.carlson@mercy.net., Carter J; Memorial Sloan Kettering Cancer Center, 641 Lexington Avenue, New York, NY, 10022, USA. Electronic address: carterj@mskcc.org., Ward LC; University of Queensland, St Lucia, Brisbane, QLD 4072, Australia. Electronic address: l.ward@uq.edu.au., Covens A; University of Toronto and Sunnybrook Health Science Centre, Toronto, ON M4N 3M5, Canada. Electronic address: al.covens@sunnybrook.ca., Tanner EJ 3rd; Northwestern Medicine, Feinberg School of Medicine, Prentice Women's Hospital, 250 E Superior, Chicago, IL 60611, USA. Electronic address: edward.tanner@nm.org., Armer JM; Sinclair School of Nursing, University of Missouri Health, DC 116.05, Ellis Fischel Cancer Center, 115 Business Loop 70 West, Columbia, MO 65203, USA. Electronic address: armer@missouri.edu., Ridner S; Vanderbilt University School of Nursing, 461 21st Ave South, Nashville, TN 37240, USA. Electronic address: sheila.ridner@vanderbilt.edu., Hayes S; Queensland University of Technology, School of Public Health and Biomedical Innovation, Queensland, Australia. Electronic address: sc.hayes@qut.edu.au., Taghian AG; Harvard Medical School/Massachusetts General Hospital, Radiation Oncology, Boston, MA 02114, USA. Electronic address: ataghian@mgh.harvard.edu., Brunelle C; Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: cbrunelle@mgh.harvard.edu., Lopez-Acevedo M; The George Washington University Hospital, School of Medicine and Health Sciences, 2150 Pennsylvania Ave, NW, Washington, DC 20037, USA. Electronic address: mlopezacevedo@mfa.gwu.edu., Davidson BA; Duke University School of Medicine, Duke Cancer Center, 20 Duke Medical Center, Durham, NC 27710, USA. Electronic address: brittany.davidson@duke.edu., Schaverien MV; The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: mvschaverien@mdanderson.org., Ghamande SA; Augusta University, Augusta Oncology, 3696 Wheeler Road, Augusta, GA 30909, USA. Electronic address: sghamande@augusta.edu., Bernas M; TCU and UNTHSC School of Medicine, Forth Worth, TX 76207, USA. Electronic address: mbernas@tcu.edu., Cheville AL; Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. Electronic address: cheville.andrea@mayo.edu., Yost KJ; Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. Electronic address: yost.kathleen@mayo.edu., Schmitz K; Penn State Cancer Institute, 400 University Drive, Hershey, PA 17033, USA. Electronic address: kzs95@psu.edu., Coyle B; Patient Advocate, Lymphedema Advocacy Group, Minneapolis, MN, USA., Zucker J; National Lymphedema Network, 411 Lafayette Street, 6th Floor, New York, NY 10003, USA. Electronic address: jeannette.zucker@lymphnet.org., Enserro D; NRG Oncology Statistics and Data Management Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Electronic address: enserrod@nrgoncology.org., Pugh S; NRG Oncology Statistics and Data Management Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 1903, USA. Electronic address: pughs@nrgoncology.org., Paskett ED; The Ohio State University, 1590 N High Street, Suite 525, Columbus, OH 43210, USA. Electronic address: electra.paskett@osumc.edu., Ford L; National Cancer Institute, Division of Cancer Prevention, 9609 Medical Center Drive, Rockville, MD 20892-9785, USA. Electronic address: fordl@mail.nih.gov., McCaskill-Stevens W; National Cancer Institute, Division of Cancer Prevention, 9609 Medical Center Drive, Rockville, MD 20892-9785, USA. Electronic address: wm57h@nih.gov.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2021 Feb; Vol. 160 (2), pp. 625-632. Date of Electronic Publication: 2020 Nov 04.

Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.

Autor: Yen TT; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, United States of America., Miyamoto T; Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan; Gynecologic Pathology Laboratroy, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America., Asaka S; Departments of Oncology and Pathology, Johns Hopkins Medical institutions, Baltimore, MD, United States of America; Department of Diagnostic Pathology, Shinshu University Hospital, Matsumoto, Japan; Department of Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Japan., Chui MH; Gynecologic Pathology Laboratroy, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America., Wang Y; Gynecologic Pathology Laboratroy, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America; Departments of Oncology and Pathology, Johns Hopkins Medical institutions, Baltimore, MD, United States of America., Lin SF; Gynecologic Pathology Laboratroy, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America; Departments of Oncology and Pathology, Johns Hopkins Medical institutions, Baltimore, MD, United States of America., Stone RL; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, United States of America., Fader AN; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, United States of America., Asaka R; Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan; Gynecologic Pathology Laboratroy, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America., Kashima H; Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan., Shiozawa T; Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan., Wang TL; Gynecologic Pathology Laboratroy, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America; Departments of Oncology and Pathology, Johns Hopkins Medical institutions, Baltimore, MD, United States of America., Shih IM; Gynecologic Pathology Laboratroy, Department of Gynecology and Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, United States of America; Departments of Oncology and Pathology, Johns Hopkins Medical institutions, Baltimore, MD, United States of America. Electronic address: ishih@jhmi.edu., Tanner EJ 3rd; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, United States of America.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2018 Sep; Vol. 150 (3), pp. 426-431. Date of Electronic Publication: 2018 Jul 04.

Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?

Autor: Fader AN; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address: afader1@jhmi.edu., Bergstrom J; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA., Jernigan A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH, USA., Tanner EJ 3rd; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA., Roche KL; Department of Gynecologic Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Stone RL; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA., Levinson KL; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA., Ricci S; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH, USA., Wethingon S; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA., Wang TL; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Shih IM; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Yang B; Department of Pathology, Cleveland Clinic, Cleveland, OH, USA., Zhang G; Department of Pathology, Cleveland Clinic, Cleveland, OH, USA., Armstrong DK; Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Gaillard S; Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Michener C; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH, USA., DeBernardo R; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH, USA., Rose PG; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH, USA.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2017 Oct; Vol. 147 (1), pp. 85-91. Date of Electronic Publication: 2017 Jul 30.

Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.

Autor: Sinno AK; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, MD, USA; Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Olive View-UCLA Medical Center, USA. Electronic address: asinno@dhs.lacounty.gov., Li X; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Thompson RE; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Tanner EJ 3rd; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, MD, USA., Levinson KL; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, MD, USA., Stone RL; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, MD, USA., Temkin SM; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, MD, USA., Fader AN; Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, MD, USA., Chi DS; Department of Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Long Roche K; Department of Gynecologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2017 Jun; Vol. 145 (3), pp. 493-499. Date of Electronic Publication: 2017 Mar 30.